Standard Biotools (LAB) Change in Receivables (2010 - 2026)
Standard Biotools (LAB) posted quarterly Change in Receivables of $1.9 million for Q1 2026, down 8.07% year-over-year from $2.0 million in Q1 2025, and up 127.61% quarter-over-quarter from -$6.7 million in Q4 2025.
Standard Biotools (LAB) Change in Receivables (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Change in Receivables for 17 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 8.07% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.2 million (up 119.14% YoY), while the FY2025 annual figure was $1.4 million, up 115.18% from the prior year.
- Change in Receivables improved to $1.9 million in Q1 2026 per LAB's latest filing, from -$6.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.2 million in Q3 2022 and bottomed at -$6.7 million in Q4 2025.
- Historically, Change in Receivables has averaged -$224705.9 across 5 years, with a median of $276000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Receivables surged 6013.33% — and 2024, when it plunged 648.29%.
- Standard Biotools' Change in Receivables stood at $60000.0 in 2022, then soared by 6013.33% to $3.7 million in 2023, then tumbled by 282.52% to -$6.7 million in 2024, then retreated by 0.52% to -$6.7 million in 2025, then surged by 127.61% to $1.9 million in 2026.
- Business Quant data shows LAB's Change in Receivables at $1.9 million in Q1 2026, -$6.7 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | - |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25 Mn |
| Jun 30, 2026 | -1.25 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | -6.73 Mn |
| Dec 31, 2025 | -6.73 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Jun 30, 2025 | 276,000.00 |
| Jun 30, 2025 | 276,000.00 |
| Mar 31, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | -6.70 Mn |
| Dec 31, 2024 | -6.70 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -686,000.00 |
| Mar 31, 2024 | -686,000.00 |